Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports By Reuters
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Source link
Similar Posts
Defence Spend Comparison
Source: Telegraph Source link
Dividend Investors: Top Canadian Energy Stocks for February
Canada’s energy market has been pumping up momentum post-pandemic as the world’s oil and gas supply chain underwent a remarkable shift. The ban on Russian oil and the Israel–Hamas war encouraged Europe to look for new suppliers of oil and natural gas. It came as an export opportunity for North American natural gas. Since then,…
Hit the Alps: Trump’s 39% Tariffs Threaten Switzerland and Franc
US President Donald Trump announced a radical measure – starting August 7, 39% tariffs will be imposed on a wide range of goods from Switzerland. This is an unprecedented blow to one of the world’s most stable economies. Traders and investors – attention: serious consequences are looming for Switzerland and the Swiss franc (CHF). Why…
AIA: Architecture Billings “Moderates” in October; Multi-family Billings Declined for 27th Consecutive Month
by Calculated Risk on 11/20/2024 12:35:00 PM Note: This index is a leading indicator primarily for new Commercial Real Estate (CRE) investment. From the AIA: ABI October 2024: Business conditions at architecture firms begin to moderate The AIA/Deltek Architecture Billings Index (ABI) score for the month was 50.3, meaning that the share of firms that…
December Vehicle Sales Forecast: 16.7 million SAAR, Up 5% YoY
by Calculated Risk on 12/20/2024 02:45:00 PM From WardsAuto: December U.S. Light-Vehicle Sales Brighten Lackluster Year; Unusually High Drain on Inventory (pay content). Brief excerpt: Improved affordability is the main thrust to the end-of-year improvement in demand, with higher consumer confidence also likely a contributing factor. But uncertainty over next year could be pulling sales…
